Cleveland BioLabs, Inc. announced that it has entered into a Consulting Agreement with Sound Clinical Solutions, SP, a consulting services provider of which Dr. Langdon Miller, the company's President and Chief Medical Officer, is sole proprietor. The Consulting Agreement replaces Dr. Miller’s previous employment agreement, which expired in accordance with its terms in July 2020. Under the Consulting Agreement, Dr. Miller will continue to serve the Company as Chief Medical Officer as an independent contractor, and not an employee, for the term of six months, unless extended by mutual agreement of the Company and Dr. Miller, or earlier terminated. The Company has agreed to pay Dr. Miller, through his consultancy, which will be focused on clinical development responsibilities associated with the development of the Company’s principal drug candidate, entolimod, as a medical radiation countermeasure, and such other duties and responsibilities associated with his continued services as Chief Medical Officer.